vs
Foghorn Therapeutics Inc.（FHTX）与Rhinebeck Bancorp, Inc.（RBKB）财务数据对比。点击上方公司名可切换其他公司
Rhinebeck Bancorp, Inc.的季度营收约是Foghorn Therapeutics Inc.的1.5倍（$13.5M vs $9.2M），Rhinebeck Bancorp, Inc.净利率更高（17.3% vs -234.3%，领先251.6%），Rhinebeck Bancorp, Inc.同比增速更快（1701.1% vs 223.8%），过去两年Foghorn Therapeutics Inc.的营收复合增速更高（35.3% vs 14.0%）
Foghorn Therapeutics是一家临床阶段生物技术企业，专注于开发靶向染色质调控系统的创新疗法，用于治疗多种癌症及其他严重疾病，目前推进多款靶向候选药物管线，通过自主研发与战略合作服务全球患者群体。
Rhinebeck Bancorp, Inc.是总部位于美国纽约的区域性银行控股企业，旗下运营莱茵贝克银行，主要面向纽约哈德逊谷地区的个人消费者与中小企业提供储蓄、贷款、抵押贷款、财富管理等零售及商业金融服务。
FHTX vs RBKB — 直观对比
营收规模更大
RBKB
是对方的1.5倍
$9.2M
营收增速更快
RBKB
高出1477.3%
223.8%
净利率更高
RBKB
高出251.6%
-234.3%
两年增速更快
FHTX
近两年复合增速
14.0%
损益表 — Q4 FY2025 vs Q4 FY2025
| 指标 | | |
|---|---|---|
| 营收 | $9.2M | $13.5M |
| 净利润 | $-21.7M | $2.3M |
| 毛利率 | — | — |
| 营业利润率 | -258.2% | 21.7% |
| 净利率 | -234.3% | 17.3% |
| 营收同比 | 223.8% | 1701.1% |
| 净利润同比 | -11.1% | 188.0% |
| 每股收益（稀释后） | $-0.35 | $0.21 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收FHTXRBKB
| Q4 25 | $9.2M | $13.5M | ||
| Q3 25 | $8.2M | $14.0M | ||
| Q2 25 | $7.6M | $13.1M | ||
| Q1 25 | $6.0M | $12.8M | ||
| Q4 24 | $2.9M | $750.0K | ||
| Q3 24 | $7.8M | $773.0K | ||
| Q2 24 | $6.9M | $10.7M | ||
| Q1 24 | $5.0M | $10.4M |
净利润FHTXRBKB
| Q4 25 | $-21.7M | $2.3M | ||
| Q3 25 | $-15.8M | $2.7M | ||
| Q2 25 | $-17.9M | $2.7M | ||
| Q1 25 | $-18.8M | $2.3M | ||
| Q4 24 | $-19.5M | $-2.7M | ||
| Q3 24 | $-19.1M | $-8.1M | ||
| Q2 24 | $-23.0M | $975.0K | ||
| Q1 24 | $-25.0M | $1.1M |
营业利润率FHTXRBKB
| Q4 25 | -258.2% | 21.7% | ||
| Q3 25 | -226.9% | 23.9% | ||
| Q2 25 | -279.2% | 26.6% | ||
| Q1 25 | -385.0% | 22.9% | ||
| Q4 24 | -840.5% | -444.9% | ||
| Q3 24 | -305.5% | -1332.3% | ||
| Q2 24 | -386.6% | 11.8% | ||
| Q1 24 | -558.3% | 13.9% |
净利率FHTXRBKB
| Q4 25 | -234.3% | 17.3% | ||
| Q3 25 | -194.4% | 19.3% | ||
| Q2 25 | -237.3% | 20.8% | ||
| Q1 25 | -316.4% | 17.9% | ||
| Q4 24 | -682.9% | -353.9% | ||
| Q3 24 | -244.9% | -1042.9% | ||
| Q2 24 | -333.6% | 9.2% | ||
| Q1 24 | -495.4% | 10.8% |
每股收益（稀释后）FHTXRBKB
| Q4 25 | $-0.35 | $0.21 | ||
| Q3 25 | $-0.25 | $0.25 | ||
| Q2 25 | $-0.28 | $0.25 | ||
| Q1 25 | $-0.30 | $0.21 | ||
| Q4 24 | $-0.23 | $-0.24 | ||
| Q3 24 | $-0.31 | $-0.75 | ||
| Q2 24 | $-0.45 | $0.09 | ||
| Q1 24 | $-0.59 | $0.10 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $80.9M | — |
| 总债务越低越好 | — | — |
| 股东权益账面价值 | $-108.5M | $136.9M |
| 总资产 | $198.1M | $1.3B |
| 负债/权益比越低杠杆越低 | — | — |
8季度趋势，按日历期对齐
现金及短期投资FHTXRBKB
| Q4 25 | $80.9M | — | ||
| Q3 25 | $89.3M | — | ||
| Q2 25 | $72.6M | — | ||
| Q1 25 | $61.0M | — | ||
| Q4 24 | $55.5M | — | ||
| Q3 24 | $57.7M | — | ||
| Q2 24 | $138.9M | — | ||
| Q1 24 | $79.3M | — |
股东权益FHTXRBKB
| Q4 25 | $-108.5M | $136.9M | ||
| Q3 25 | $-89.7M | $133.0M | ||
| Q2 25 | $-76.7M | $129.0M | ||
| Q1 25 | $-61.7M | $126.0M | ||
| Q4 24 | $-45.5M | $121.8M | ||
| Q3 24 | $-28.3M | $122.7M | ||
| Q2 24 | $-14.3M | $116.2M | ||
| Q1 24 | $-97.5M | $114.3M |
总资产FHTXRBKB
| Q4 25 | $198.1M | $1.3B | ||
| Q3 25 | $205.0M | $1.3B | ||
| Q2 25 | $226.2M | $1.3B | ||
| Q1 25 | $258.7M | $1.3B | ||
| Q4 24 | $284.0M | $1.3B | ||
| Q3 24 | $308.4M | $1.3B | ||
| Q2 24 | $328.6M | $1.3B | ||
| Q1 24 | $255.0M | $1.3B |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $-22.3M | $11.7M |
| 自由现金流经营现金流 - 资本支出 | — | $10.9M |
| 自由现金流率自由现金流/营收 | — | 80.6% |
| 资本支出强度资本支出/营收 | 0.0% | 6.3% |
| 现金转化率经营现金流/净利润 | — | 5.03× |
| 过去12个月自由现金流最近4个季度 | — | $19.4M |
8季度趋势，按日历期对齐
经营现金流FHTXRBKB
| Q4 25 | $-22.3M | $11.7M | ||
| Q3 25 | $-18.9M | $2.2M | ||
| Q2 25 | $-21.0M | $2.4M | ||
| Q1 25 | $-24.0M | $4.3M | ||
| Q4 24 | $-24.5M | $8.5M | ||
| Q3 24 | $-21.0M | $-3.6M | ||
| Q2 24 | $-25.5M | $12.0M | ||
| Q1 24 | $-29.3M | $-3.5M |
自由现金流FHTXRBKB
| Q4 25 | — | $10.9M | ||
| Q3 25 | — | $2.0M | ||
| Q2 25 | $-21.0M | $2.2M | ||
| Q1 25 | $-24.0M | $4.2M | ||
| Q4 24 | $-25.0M | $7.7M | ||
| Q3 24 | $-21.3M | $-3.6M | ||
| Q2 24 | $-25.6M | $11.8M | ||
| Q1 24 | $-29.4M | $-3.7M |
自由现金流率FHTXRBKB
| Q4 25 | — | 80.6% | ||
| Q3 25 | — | 14.5% | ||
| Q2 25 | -278.2% | 17.2% | ||
| Q1 25 | -403.2% | 32.8% | ||
| Q4 24 | -875.3% | 1023.9% | ||
| Q3 24 | -273.0% | -469.0% | ||
| Q2 24 | -371.0% | 111.1% | ||
| Q1 24 | -583.1% | -36.0% |
资本支出强度FHTXRBKB
| Q4 25 | 0.0% | 6.3% | ||
| Q3 25 | 0.0% | 1.4% | ||
| Q2 25 | 0.3% | 1.4% | ||
| Q1 25 | 0.5% | 0.9% | ||
| Q4 24 | 16.8% | 105.5% | ||
| Q3 24 | 4.0% | 6.3% | ||
| Q2 24 | 0.2% | 1.2% | ||
| Q1 24 | 2.0% | 2.3% |
现金转化率FHTXRBKB
| Q4 25 | — | 5.03× | ||
| Q3 25 | — | 0.83× | ||
| Q2 25 | — | 0.89× | ||
| Q1 25 | — | 1.89× | ||
| Q4 24 | — | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | 12.27× | ||
| Q1 24 | — | -3.12× |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
